2016
DOI: 10.1021/jacs.6b04910
|View full text |Cite
|
Sign up to set email alerts
|

A Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent Inhibitors

Abstract: Human macrophage migration inhibitory factor (MIF) is both a keto–enol tautomerase and a cytokine associated with numerous inflammatory diseases and cancer. Consistent with observed correlations between inhibition of the enzymatic and biological activities, discovery of MIF inhibitors has focused on monitoring the tautomerase activity using l-dopachrome methyl ester or 4-hydroxyphenyl pyruvic acid as substrates. The accuracy of these assays is compromised by several issues including substrate instability, spec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

9
87
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 37 publications
(96 citation statements)
references
References 33 publications
(107 reference statements)
9
87
0
Order By: Relevance
“…37 The activity of Orita-13 has been reported to be similar to ISO-1. 27 The most potent chromene compounds were active at lower concentrations compared to the reference compound ISO-1. Therefore, compounds 10 and 17 were taken for further investigation.…”
Section: Resultsmentioning
confidence: 96%
“…37 The activity of Orita-13 has been reported to be similar to ISO-1. 27 The most potent chromene compounds were active at lower concentrations compared to the reference compound ISO-1. Therefore, compounds 10 and 17 were taken for further investigation.…”
Section: Resultsmentioning
confidence: 96%
“…The results were confirmed by measurement of Kd values in a fluorescence polarization assay. [12] Exemplary potent compounds are 1 (NVS-2[10]) and 2[11] with Ki values of ca. 0.03 μM, which are ca.…”
mentioning
confidence: 99%
“…[6,11,12] Though there are more than 125 approved drugs that contain a phenolic group including, for example, acetaminophen, albuterol, amoxicillin, raloxifene, and doxycycline, the oral bioavailability of phenols is well-known to often be unacceptably low owing to metabolic glucoronidation[14] and/or sulfation. [15] Thus, we set out to find a phenol-free series of MIF tautomerase inhibitors with low-nanomolar potencies.…”
mentioning
confidence: 99%
See 2 more Smart Citations